ADX48621

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	5

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05116813 (ClinicalTrials.gov)	October 25, 2021	1/11/2021	Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Le ...	An Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving ...	Parkinson Disease;Dyskinesia, Drug-Induced;Dyskinesias	Drug: Dipraglurant	Addex Pharma S.A.	NULL	Recruiting	30 Years	85 Years	All	140	Phase 2/Phase 3	United States
2	NCT04857359 (ClinicalTrials.gov)	August 6, 2021	21/4/2021	Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-ba ...	Phase 2b/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy o ...	Parkinson Disease;Dyskinesia, Drug-Induced;Dyskinesias	Drug: Dipraglurant;Drug: Placebo	Addex Pharma S.A.	NULL	Recruiting	30 Years	85 Years	All	140	Phase 2/Phase 3	United States
3	EUCTR2010-022517-25-DE (EUCTR)	30/05/2011	14/02/2011	Safety, tolerability and efficacy of ADX48621 in patients with Parkinson's disease	Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate ...	Levodopa induced dyskinesia in Parkinson's disease patients MedDRA version: 13.1;Level: PT;Classific ...	Product Name: ADX48621 Product Code: ADX48621 INN or Proposed INN: Dipraglurant	Addex Pharma SA	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 2	United States;France;Austria;Germany
4	EUCTR2010-022517-25-AT (EUCTR)	15/04/2011	17/02/2011	Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate ...	Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate ...	Levodopa induced dyskinesia in Parkinson's disease patients MedDRA version: 14.0;Level: PT;Classific ...	Product Name: ADX48621 Product Code: ADX48621 INN or Proposed INN: Dipraglurant	Addex Pharma SA	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 2	United States;France;Austria;Germany
5	NCT01336088 (ClinicalTrials.gov)	April 2011	4/4/2011	ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease	Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate ...	Parkinson's Disease	Drug: ADX48621;Drug: Placebo	Addex Pharma S.A.	NULL	Completed	30 Years	75 Years	Both	83	Phase 2	United States;Austria;France;Germany

First Previous1Next Last